Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M320,588Revenue (TTM) $M70,182Net Margin (%)21.9Altman Z-Score5.5
Enterprise Value $M304,082EPS (TTM) $5.5Operating Margin %25.9Piotroski F-Score6
P/E(ttm)21.2Beneish M-Score-2.6Pre-tax Margin (%)27.0Higher ROA y-yY
Price/Book4.410-y EBITDA Growth Rate %4.0Quick Ratio2.5Cash flow > EarningsY
Price/Sales4.75-y EBITDA Growth Rate %5.9Current Ratio2.8Lower Leverage y-yN
Price/Free Cash Flow22.4y-y EBITDA Growth Rate %-10.1ROA % (ttm)11.6Higher Current Ratio y-yY
Dividend Yield %2.6PEG3.6ROE % (ttm)21.7Less Shares Outstanding y-yY
Payout Ratio %55.0Shares Outstanding M2,751ROIC % (ttm)26.9Gross Margin Increase y-yN

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JNJTweedy Browne 2016-03-31 Reduce-0.93%$95.75 - $109.14
($103.39)
$ 116.5513%Reduce -8.39%3,383,445
JNJFirst Eagle Investment 2016-03-31 Reduce-0.49%$95.75 - $109.14
($103.39)
$ 116.5513%Reduce -62.31%1,142,872
JNJYacktman Focused Fund 2016-03-31 Reduce-0.45%$95.75 - $109.14
($103.39)
$ 116.5513%Reduce -8.00%2,300,000
JNJT Rowe Price Equity Income Fund 2016-03-31 Reduce-0.33%$95.75 - $109.14
($103.39)
$ 116.5513%Reduce -15.23%3,961,300
JNJRobert Olstein 2016-03-31 Reduce-0.28%$95.75 - $109.14
($103.39)
$ 116.5513%Reduce -29.58%50,000
JNJJoel Greenblatt 2016-03-31 Add0.24%$95.75 - $109.14
($103.39)
$ 116.5513%Add 511.44%242,043
JNJDonald Yacktman 2016-03-31 Reduce-0.18%$95.75 - $109.14
($103.39)
$ 116.5513%Reduce -3.22%7,080,500
JNJJohn Rogers 2016-03-31 Add0.03%$95.75 - $109.14
($103.39)
$ 116.5513%Add 2.31%850,915
JNJRuane Cunniff 2016-03-31 Reduce-0.03%$95.75 - $109.14
($103.39)
$ 116.5513%Reduce -78.50%13,925
JNJTom Gayner 2016-03-31 Add0.02%$95.75 - $109.14
($103.39)
$ 116.5513%Add 0.93%610,800
JNJKen Fisher 2016-03-31 Add0.01%$95.75 - $109.14
($103.39)
$ 116.5513%Add 0.35%10,854,263
JNJRichard Pzena 2016-03-31 Add0.01%$95.75 - $109.14
($103.39)
$ 116.5513%Add 0.92%1,185,329
JNJCharles Brandes 2016-03-31 Reduce-0.01%$95.75 - $109.14
($103.39)
$ 116.5513%Reduce -3.20%146,253
JNJMario Gabelli 2016-03-31 Add$95.75 - $109.14
($103.39)
$ 116.5513%Add 1.60%337,588
JNJBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Reduce$95.75 - $109.14
($103.39)
$ 116.5513%Reduce -0.10%15,327,465
JNJDodge & Cox 2016-03-31 Reduce$95.75 - $109.14
($103.39)
$ 116.5513%Reduce -1.77%34,808
JNJTweedy Browne 2015-12-31 Reduce-0.45%$93.42 - $105.25
($100.75)
$ 116.5516%Reduce -4.22%3,693,349
JNJFirst Eagle Investment 2015-12-31 Add0.37%$93.42 - $105.25
($100.75)
$ 116.5516%Add 91.19%3,032,177
JNJYacktman Focused Fund 2015-12-31 Reduce-0.17%$93.42 - $105.25
($100.68)
$ 116.5516%Reduce -3.85%2,500,000
JNJDonald Yacktman 2015-12-31 Reduce-0.15%$93.42 - $105.25
($100.75)
$ 116.5516%Reduce -3.23%7,316,129
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JNJ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pruden Gary JExec VP, WW Chair, Med Devices 2016-06-07Sell9,735$116.03-0.03view
Kapusta Ronald AController, CAO 2016-06-07Sell3,000$115.790.18view
Kapusta Ronald AController, CAO 2016-05-10Sell3,957$114.771.07view
Stoffels PaulusChief Scientific Officer 2016-02-17Sell125,000$102.4313.25view
Fasolo PeterVP, Global Human Resources 2016-02-03Sell151,385$104.1211.41view
Ullmann Michael HVP, General Counsel 2015-11-20Sell17,650$102.4713.2view
Caruso Dominic JVP, Finance; CFO 2015-11-02Sell20,569$102.2113.49view
Kapusta Ronald AController, CAO 2015-10-23Sell6,239$99.6816.37view
PRINCE CHARLESDirector 2015-08-06Buy2,500$99.2516.88view
PRINCE CHARLESDirector 2015-06-02Buy2,500$99.2216.91view

Press Releases about JNJ :

Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    Opinions Differ on Abbott Deal to Acquire St. Jude's Medical Jun 18 2016 
    Get Higher Returns and More Dividend Income – In Less Time With Less Risk Jun 17 2016 
    15 Years With Johnson & Johnson Jun 14 2016 
    How to Create Intergenerational Wealth Jun 06 2016 
    'Party Drug' Could Be Johnson & Johnson's Entry Into Antidepressant Market May 22 2016 
    U.S. Stocks Trade Flat at Start of Week May 09 2016 
    Johnson & Johnson a Legendary Dividend Stock May 08 2016 
    UnitedHealth’s Obamacare Changes to Affect Healthcare Sector Apr 27 2016 
    Johnson & Johnson Beats 1st-Quarter Expectations, Improves Guidance Apr 27 2016 
    How to Know When You Can Retire With Dividend Investing Apr 13 2016 

    More From Other Websites
    This 5-Stock Portfolio Makes the Perfect Summer Gift Jun 27 2016
    50 Stocks to Brighten the Post-Brexit Blues Jun 27 2016
    The One Stock to Immunize Your Portfolio From the Brexit Contagion Jun 27 2016
    10 Best Post-Brexit Stocks to Buy at a Discount Now Jun 27 2016
    How Did Roche’s Diagnostics Division Perform? Jun 25 2016
    Johnson & Johnson :JNJ-US: Earnings Analysis: Q1, 2016 By the Numbers : June 24, 2016 Jun 24 2016
    Gilead's (GILD) HIV Treatment Odefsey Gains Approval in EU Jun 24 2016
    There's Value in This High-Dividend ETF Jun 24 2016
    Gilead Sciences Get European Commission Grant For Marketing Authorization Of Its Single Tablet... Jun 23 2016
    A Secure 4% 'No Withdrawal' Retirement Portfolio Jun 22 2016
    Technology Forces Advertisers To Get Creative Jun 22 2016
    Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice... Jun 22 2016
    Johnson & Johnson Names Joseph Wolk As VP Of Investor Relations In Place Of Louise Mehrotra Jun 22 2016
    Johnson & Johnson Announces Retirement of Louise Mehrotra and Appointment of Joseph Wolk as Vice... Jun 22 2016
    Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results Jun 21 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)